Evaluation and management of patients with heart disease and cancer: cardio-oncology - Wikidata - awgldk - TriplyDB

Evaluation and management of patients with heart disease and cancer: cardio-oncology

Evaluation and management of patients with heart disease and cancer: cardio-oncology

http://www.wikidata.org/entity/Q26998273

about

Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy Cardiovascular Disease in Women: Clinical Perspectives.Cardio-oncology: what you need to know now for clinical practice and echocardiography.Clinical Experience of Patients Referred to a Multidisciplinary Cardiac Oncology Clinic: An Observational Study.Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.Incidence and trends of cardiovascular mortality after common cancers in young adults: Analysis of surveillance, epidemiology and end-results program Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.Cardio-oncology: an ongoing evolution.Systems biology approaches to adverse drug effects: the example of cardio-oncology.Cardio-oncology: cardiovascular complications of cancer therapy.Echocardiographic Assessment of Cardiotoxic Effects of Cancer Therapy.Cardiotoxicity from the cardiologist's perspective.Left ventricular ejection fraction in advanced cancer patients: a valuable prognostic tool?Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.Cardio-oncology.Speckle-tracking global longitudinal strain as an early predictor of cardiotoxicity in breast carcinoma.Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity.Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.Should vascular effects of newer treatments be addressed more completely?Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.The Framingham risk score underestimates the risk of cardiovascular events in the HER2-positive breast cancer population.The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis.Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013.Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer.Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.[Current recommendations for diagnostic echocardiography in cancer patients : Is echocardiography too late or too early?]Lung cancer as a cardiotoxic state: a review."Cardio-Oncology": Implications for interventionists.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines Towards evidence-based management of patients treated with cardiotoxic chemotherapy: A collaborative effort of cardiologists and oncologists Cardio-oncology: A Focus on Cardiotoxicity Guest Editorial: Is Cardio-oncology Ready for Algorithms?Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction

P2860

Q26740352-EED14D42-9FC4-411A-B189-09073F1646DB Q26797138-AC1F1719-CEC1-4A7F-BE80-4FDCD170D59D Q30743765-D05627CC-A806-4F71-9D7D-00B29DFC725C Q33701308-9B70CAE4-EB0F-4BA0-8E19-BE379B6070B3 Q35957861-13EF1C87-5594-4362-9C96-08436C3ECCFA Q36163330-8F5E72EF-1435-4E4F-8422-52E01D988F35 Q36451899-D46330D4-06A3-465B-BA0F-5BC1D1EF3CD5 Q36551901-1FD0E263-43B8-4E4C-879A-1F7FD8353185 Q36601680-E058C6BD-20FA-4902-92B8-C445BC78C584 Q37035108-4BA0A211-177C-498E-A55C-AD6CA4B09916 Q37311943-ACC5AF9D-3970-4BCC-9DD6-033F1A23ED41 Q38551766-A9822B18-E245-4345-BD9B-1F10A8E88B98 Q38606067-DF6DE092-FAB3-4A40-9E38-128FAFD1F500 Q38665281-60865E8F-D8E5-425F-BA1F-5588D2A660DF Q38938410-5E4CD873-07C9-4A63-805F-9B1B7AFFA47F Q38978582-562EB5E9-1851-465D-85CA-C30299E81489 Q38982319-4C4C8B34-59BB-4B2E-9748-E10F4DD882E4 Q39018351-287522F6-4CFC-4DF0-B8E5-43CD6EB2BF0C Q39076609-731EB862-7AB8-4E40-96FE-4D62CE75919B Q39962402-7FFA3DE1-25CF-4685-A7AC-26AF97EBB42C Q40500474-DB587859-A3F2-44A1-805A-76643A5CA411 Q41288150-BCDBFBC5-8B46-4E79-9323-362FB9204642 Q44242155-35BB3B21-B824-495F-984D-1AEAFE23504E Q45073135-4365F1A7-41D4-453C-8380-DADB03F18B90 Q47155288-AF0C5DD5-11D4-4D45-8C18-71E9359AA461 Q47610317-12A7E32A-2B1C-4953-9CB6-1401A57BAF7D Q48168034-4949EF0D-4FA9-4485-A8DB-714F6A0890A5 Q48635788-447E2FD0-9E93-408D-8040-B2E81B8B8A9D Q49287618-0DB48BF4-DA4A-45CD-8A5C-1C245045BDCA Q50079226-074C8D7D-FDDD-4BC2-8AA4-44FD3818596B Q50418924-79D13B32-1518-4FB2-8349-F3062917B962 Q53117997-4B2DD0DC-5EDC-44F3-A3D9-6F0249D63897 Q54139999-3334B5DB-D7F7-4063-92DA-681A0BCCC5C6 Q57057499-9AA2A761-AF0C-40B2-A98D-5072FA8EBD0F Q57060411-51F2381E-58FF-4975-B006-E75BB01AD6B4 Q57495835-6773FA29-4701-406D-8296-AA39231B9FDA Q57495837-03544EF1-77EA-4141-9478-6234816BA007 Q58130037-4D27EB37-6191-403D-B197-D66BF02962E8

P2860

Evaluation and management of patients with heart disease and cancer: cardio-oncology

http://www.wikidata.org/entity/Q26998273

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@ast

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@en

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@nl

type

label

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@ast

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@en

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@nl

prefLabel

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@ast

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@en

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@nl

P1433

Q26998273-7B511CED-B5DE-47A0-B14B-4FF5DE90E2F9

P1476

Q26998273-A5ABBD82-4300-42A8-ABBC-BFE0A07E8314

P2093

Q26998273-22B788F5-023E-4346-883A-03D0B491C674

Q26998273-4051BBA0-6339-4712-8B1C-9357BFF87260

Q26998273-5763BB21-6B96-4D86-B01E-4A4C7D121BC9

Q26998273-7C254B8A-1301-47B2-ABA3-6E538107A12A

Q26998273-E868CD14-7EFC-49EC-A41B-78AF9A82C180

P2860

Q26998273-03B87E19-260E-4311-95BE-0B0E663EB942

Q26998273-0466B6DA-4242-40E9-82E8-2D660B583228

Q26998273-04FC4C58-28CD-44D2-9A76-564076E057BE

Q26998273-0753A88F-160E-4E48-B6D5-DD36560D1030

Q26998273-07F4E1B1-D70A-47E6-9EFC-4297540A1FFF

Q26998273-0A3EAABE-353B-404C-84E1-94B65EBB74FE

Q26998273-0B8D4E75-E456-4FD7-BEB2-B5C70C73EE0D

Q26998273-0CA3AE0E-0F44-45FA-A198-0C3F4825A4AC

Q26998273-0F2F3C0C-4742-4E45-A3A7-CC2BEDBF3049

Q26998273-14E61AE8-DB0E-44F2-9CAE-4CDBF646FB4E

P304

Q26998273-D9DFFFFB-69F0-490E-A884-28952DF569A6

P31

Q26998273-02F9A89D-A024-430A-B595-48C3B16739B2

P3181

Q26998273-4A6EAE3A-92D4-4CEE-9D69-D560EB081B05

P356

Q26998273-2CE0139C-A2F0-4831-ACB2-3B21BB9F15F3

P407

Q26998273-5F0D3C4D-A9D2-4D2D-B6EC-852D02E12350

P433

Q26998273-2CFFDF71-81AD-4150-852C-F9E607741EF4

P478

Q26998273-5A6F9850-333B-4F76-8B57-EF7B027F02C2

P50

Q26998273-68CB1525-063D-4E7C-81A8-577CB19438EC

P577

Q26998273-3F5DF722-BA9E-40F4-84F3-FB4847A5F2C0

P5875

Q26998273-2E63FE47-A287-46E3-9FE9-FFA2ADBCA0E7

P698

Q26998273-6B78322E-9CF3-4170-8600-E906C1AFDE9E

P921

Q26998273-0E7A5E45-2C37-4E35-9432-B8DB6BF416CF

P932

Q26998273-160C85B2-3F37-45C5-B053-A9A53F9C0CDD

P3181

P356

J.MAYOCP.2014.05.013

P1433

Mayo Clinic Proceedings

P1476

Evaluation and management of patients with heart disease and cancer: cardio-oncology

@en

P2093

Hector R. Villarraga

http://www.w3.org/2001/XMLSchema#string

Joerg Herrmann

http://www.w3.org/2001/XMLSchema#string

Manish Kohli

http://www.w3.org/2001/XMLSchema#string

Nicole P. Sandhu

http://www.w3.org/2001/XMLSchema#string

Sharon L. Mulvagh

http://www.w3.org/2001/XMLSchema#string

P2860

Cardioprotective interventions for cancer patients receiving anthracyclines

Cardiac dysfunction in the trastuzumab clinical trials experience

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography.

Cardio-oncology: a new medical issue.

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

P304

1287-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

782850

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.MAYOCP.2014.05.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265338592

http://www.w3.org/2001/XMLSchema#string

P698

25192616

http://www.w3.org/2001/XMLSchema#string

P921

P932

4258909

http://www.w3.org/2001/XMLSchema#string